Mercado global de testes de anemia perniciosa – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de testes de anemia perniciosa

Espera-se que o mercado de testes de anemia perniciosa ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para contabilizar 23,22 mil milhões de dólares até 2028 e crescerá a um CAGR de 5, 10% no período de previsão acima referido.

A elevada prevalência da condição tem aumentado a um ritmo significativo, motivando e elevando o crescimento do mercado de testes de anemia perniciosa. Além disso, a crescente prevalência de doenças autoimunes ou doenças intestinais impulsiona ainda mais a elevada taxa de adoção no mercado de testes de anemia perniciosa. Além disso, o elevado desenvolvimento de produtos em pipeline, juntamente com o elevado número de mulheres em idade reprodutiva, estão também a alimentar a procura do mercado de testes de anemia perniciosa durante o período previsto de 2021 a 2028. O estilo de vida pouco saudável e as complicações durante a gravidez, principalmente nas economias em desenvolvimento, estão também a influenciar excessivamente o crescimento do mercado de testes de anemia perniciosa.

Além disso, o aumento da população geriátrica, a disponibilidade de medicamentos eficazes para as doenças autoimunes, a I&D robusta e a melhoria das infraestruturas de saúde também estão a contribuir para o crescimento do mercado. Embora se espere que a falta de sensibilização para a saúde em vários países em desenvolvimento e o elevado custo dos medicamentos impeçam o crescimento do mercado de testes de anemia perniciosa no período de previsão acima referido. Além disso, a ingestão de uma dieta deficiente em vitaminas também está a impulsionar o crescimento do mercado de testes de anemia perniciosa.

A crescente I&D no desenvolvimento de novos métodos de tratamento, bem como as regulamentações governamentais de apoio estão também a oferecer oportunidades de crescimento significativas para o mercado no período de previsão de 2021 a 2028.

This pernicious anemia testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on pernicious anemia testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pernicious Anemia Testing Market Scope and Market Size

Pernicious anemia testing market is segmented on the basis of diagnosis test, route of administration, test type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on diagnosis type, the pernicious anemia testing market is segmented into complete blood count test, vitamin b-12 deficiency test, biopsy and intrinsic factor deficiency test.
• On the basis of route of administration, the pernicious anemia testing market is segmented into parenteral, oral, nasal, and topical.
• The test type segment of the pernicious anemia testing market is segmented into vitamin B-12 injections and vitamin B-12 pills.
• On the basis of end user, the pernicious anemia testing market is segmented into hospitals, diagnostic centers and clinics and homecare.

Pernicious Anemia Testing Market Country Level Analysis

Pernicious anemia testing market is analyzed and market size insights and trends are provided by country, diagnosis test, route of administration, test type and end user as referenced above.

The countries covered in the  pernicious anemia testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the pernicious anemia testing market owing to the healthcare facilities for such diseases and large number of geriatric populations in the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 owing to the rapid development in the economies and large investment in the healthcare sector in this particular region.

The country section of the pernicious anemia testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Pernicious anemia testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for pernicious anemia testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the pernicious anemia testing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Pernicious Anemia Testing Market Share Analysis

Pernicious anemia testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to pernicious anemia testing market.

Os principais players abordados no relatório de mercado de testes de anemia perniciosa são AMAG Pharmaceuticals, Siemens Healthcare Private Limited, Pfizer, Inc., Thermo Fisher Scientific Inc., BBI Group, Monobind, Inc., Bio-Rad Laboratories, Inc., GlaxoSmithKline plc, Medline Industries, Inc., Cleveland HeartLab, Inc., Trinity Biotech PLC, Mayo Foundation for Medical Education and Research (MFMER), Laboratory Corporation of America, Takeda Pharmaceutical Company Limited, Emisphere Technologies, DAIICHI SANKYO COMPANY, LIMITED, Sanofi, The Synergy Company, Endo International plc, Merck KGaA e PHARMACOSMOS A/S, entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-57459